Moderate evidence suggests that algal omega-3s are bioequivalent to fish sources, effectively increasing DHA levels in the body. Additionally, omega-3 supplementation is linked to reduced cardiovascular events, though more research could strengthen these findings.
DHA bioavailability from algal oil versus fish/salmonHealthy adults aged 20–65 years · Randomized open-label parallel-group bioequivalence trialModerate
DHA levels in plasma phospholipids increased ~80% & in erythrocytes ~25% with both algal-oil capsules & cooked salmon; the two sources were bioequivalent in raising plasma & red blood cell DHA, supporting algal oil as a non-fish DHA source.
Cardiovascular outcomes & mortalityGeneral adults and cardiovascular risk populations · Systematic review and meta-analysisModerate
Omega-3 supplementation (including algal-derived DHA/EPA) associated with reductions in cardiovascular events; evidence supports algal oil as a functionally equivalent omega-3 source.
Cardiovascular Longevity Support
This stack combines algal omega-3 EPA/DHA & pterostilbene to support cardiovascular health & longevity. Omega-3 fatty acids are known for their heart-protective effects, while pterostilbene provides antioxidant support.
Vegetarian Omega Longevity Base
Plant-based omega-3 support for long-term cardiometabolic health.
Forms & usage▾
Take 1-2 capsules daily with meals for optimal absorption.